Form 8-K - Current report:
SEC Accession No. 0001171843-25-000194
Filing Date
2025-01-13
Accepted
2025-01-13 08:01:15
Documents
34
Period of Report
2025-01-13
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_011325.htm   iXBRL 8-K 19456
2 EXHIBIT 99.1 exh_991.htm EX-99.1 33829
6 GRAPHIC exh991_01.jpg GRAPHIC 64345
7 GRAPHIC exh991_02.jpg GRAPHIC 135468
8 GRAPHIC exh991_03.jpg GRAPHIC 111895
9 GRAPHIC exh991_04.jpg GRAPHIC 132541
10 GRAPHIC exh991_05.jpg GRAPHIC 178018
11 GRAPHIC exh991_06.jpg GRAPHIC 201037
12 GRAPHIC exh991_07.jpg GRAPHIC 191660
13 GRAPHIC exh991_08.jpg GRAPHIC 128568
14 GRAPHIC exh991_09.jpg GRAPHIC 121414
15 GRAPHIC exh991_10.jpg GRAPHIC 127936
16 GRAPHIC exh991_11.jpg GRAPHIC 125087
17 GRAPHIC exh991_12.jpg GRAPHIC 139093
18 GRAPHIC exh991_13.jpg GRAPHIC 139688
19 GRAPHIC exh991_14.jpg GRAPHIC 134101
20 GRAPHIC exh991_15.jpg GRAPHIC 131130
21 GRAPHIC exh991_16.jpg GRAPHIC 118321
22 GRAPHIC exh991_17.jpg GRAPHIC 110742
23 GRAPHIC exh991_18.jpg GRAPHIC 144369
24 GRAPHIC exh991_19.jpg GRAPHIC 167187
25 GRAPHIC exh991_20.jpg GRAPHIC 34951
  Complete submission text file 0001171843-25-000194.txt   3871679

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE apto-20250113.xsd EX-101.SCH 3030
4 XBRL LABEL FILE apto-20250113_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE apto-20250113_pre.xml EX-101.PRE 22369
36 EXTRACTED XBRL INSTANCE DOCUMENT f8k_011325_htm.xml XML 3918
Mailing Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6
Business Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6 310-849-8060
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 25524880
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)